新闻发布

Harbin, China, Feb. 25, 2009 -- China Sky One Medical, Inc. (“China Sky One Medical” or “the Company”) (NASDAQ: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China (“PRC”), today announced that its wholly owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, has expanded the sale of its Sumei Slim Patch into South Korea and Sudan. As a result, the product is now available in 26 countries and regions.

Harbin, China, Feb. 24, 2009 -- China Sky One Medical, Inc. (“China Sky One Medical” or “the Company”) (NASDAQ: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China (“PRC”), today announced that its wholly owned subsidiary, Peng Lai Jin Chuang Pharmaceutical Company (“Jin Chuang”), signed an exclusive distribution agreement with Shaanxi Buchang Group (“Buchang”) for Naftopidil Dispersible tablets with an expected sales target of 100 million RMB (US $14.6 million) over five years.

Taian City, Shandong Province, PRC - February 11, 2009 - China Biologic Products, Inc. (CBPO.OB) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Company’s indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. (“Shandong Taibang”) has been awarded the High-Technology Enterprise Certification (the "Certification”) by the provincial government in Shandong Province.